|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2004-2-13
|
|
pubmed:abstractText |
Pharmacological treatment with the beta2-adrenoceptor agonist clenbuterol is known to induce a slow-to-fast fibre type and myosin heavy chain (MHC) isoform transition in intact muscle. This study examined the sensitivity of regenerated soleus muscle to 4 weeks of clenbuterol treatment (2 mg kg-1 day-1).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0001-6772
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
180
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
271-80
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:14962009-Adrenergic beta-Agonists,
pubmed-meshheading:14962009-Animals,
pubmed-meshheading:14962009-Blotting, Western,
pubmed-meshheading:14962009-Body Weight,
pubmed-meshheading:14962009-Clenbuterol,
pubmed-meshheading:14962009-Female,
pubmed-meshheading:14962009-Immunohistochemistry,
pubmed-meshheading:14962009-Isomerism,
pubmed-meshheading:14962009-Muscle, Skeletal,
pubmed-meshheading:14962009-Muscle Fibers, Skeletal,
pubmed-meshheading:14962009-MyoD Protein,
pubmed-meshheading:14962009-Myosin Heavy Chains,
pubmed-meshheading:14962009-Organ Size,
pubmed-meshheading:14962009-Rats,
pubmed-meshheading:14962009-Rats, Wistar
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Clenbuterol treatment affects myosin heavy chain isoforms and MyoD content similarly in intact and regenerated soleus muscles.
|
|
pubmed:affiliation |
Department of Human Factors, Centre de recherches du service de santé des armées, La Tronche Cedex, France.
|
|
pubmed:publicationType |
Journal Article
|
